By Admin at 28 Apr 2016
A new implantable device, developed by researchers from MIT and Massachusetts General Hospital, may allow for more targeted pancreatic-cancer treatment that is up to 12 times more effective than delivering chemotherapy drugs via intravenous injection.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
